Emergency Medicine

CRN launches new labeling guidelines for melatonin supplements

April 17, 2024 - On April 15, 2024, the Council for Responsible Nutrition (CRN), one of the most prominent trade associations for the dietary supplements industry, issued a statement highlighting new labeling guidelines for all gummy supplements, specifically melatonin gummy supplements. Melatonin supplements have recently been critiqued for a lack of regulation...

Read More


More Articles

Taking Anti-Inflammatory Medication with Plan B Improves Effectiveness

by Veronica Salib

A new study published in the Lancet provides a new route for improving the effectiveness of oral emergency contraceptives. According to the study, taking an anti-inflammatory pill alongside Plan B...

Neutralizing Monoclonal Antibodies for COVID-19 Reduces ED Visits

by Veronica Salib

On April 24, 2023, researchers published the results of a cohort study analyzing the effect of neutralizing monoclonal antibodies (nMABs) on patients with COVID-19, noting significantly improved...

Achieving Adequate Pain Management, Pharmacological Indications

by Veronica Salib

Data from the CDC suggests that, as of 2018, approximately 20.4% of adults in the United States were living with chronic pain. Additionally, 8% of US adults had high-impact chronic pain. Pain management is essential in healthcare, as...

Motivational Interventions May Improve SUD Recovery

by Veronica Salib

On October 21, 2022, JAMA Network Open published the results of a randomized clinical trial on the effects of emergency room motivational interventions on substance use disorders (SUD). Using a cohort...

Orexo Pharmaceuticals Announces Nasal Adrenaline Clinical Development

by Veronica Salib

On July 5, 2022, Orexo Pharmaceuticals announced plans to begin clinical development of a nasal adrenaline rescue medication. This study, called OX640-001, is looking at OX640, which is a nasal...

FDA Gives EUA for Genentech’s Actemra for COVID-19 Hospitalizations

by Kyle Murphy, PhD

Genentech’s COVID-19 drug therapy Actemra (tocilizumab) is the latest to receive an emergency use authorization, FDA announced Thursday. The EUA makes the drug available to treat hospitalized...

EU Grants Emergency Use for Moderna’s mRNA COVID-19 Vaccine

by Samantha McGrail

Moderna recently announced that the European Commission (EU) granted conditional marketing authorization (CMA) for its mRNA COVID-19 vaccine.  The authorization of COVID-19 Vaccine Moderna,...

UK Authorizes Emergency Use of AstraZeneca’s COVID-19 Vaccine

by Samantha McGrail

AstraZeneca recently announced that its COVID-19 vaccine has been approved for emergency supply in the United Kingdom (UK).  This is the first emergency authorization for COVID-19 Vaccine...

More Positive Data Released for Pfizer-BioNTech COVID-19 Vaccine

by Samantha McGrail

A two-dose regimen of Pfizer and BioNTech’s mRNA COVID-19 vaccine, BNT162b2, elicited 95 percent protection against the coronavirus in individuals 16 years of age or older, according to a recent...

FDA Issues EUA for Abbott’s At-Home COVID-19 Antigen Test

by Samantha McGrail

FDA recently issued an emergency use authorization (EUA) for Abbott’s COVID-19 antigen test, the BinaxNOW COVID-19 Ag Card Home Test, for use by patients with a prescription.  The test is...

FDA Says It Will Approve EUA for Pfizer’s COVID-19 Vaccine

by Samantha McGrail

Following a positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, FDA stated that it will rapidly work toward finalization and issuance of an emergency use...

Roche Receives FDA Approval for COVID-19 Antibody Test

by Samantha McGrail

Roche recently announced that its COVID-19 antibody test, Elecsys, received FDA emergency use authorization. Elecsys Anti-SARS-CoV-2 S measures the level of antibodies to the spike protein of...

UK Approves COVID-19 Vaccine from Pfizer, BioNTech

by Samantha McGrail

Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK has granted a temporary emergency use authorization to Pfizer and BioNTech for their COVID-19 mRNA vaccine, BNT162b2. This is the...

FDA Grants Emergency Use to Regeneron’s COVID-19 Antibody Cocktail

by Samantha McGrail

FDA recently issued an emergency use authorization to Regeneron for its COVID-19 antibody cocktail, formerly known as REGN-COV2.  The cocktail is made up of casirivimab and imdevimab. The...

Overcoming the Challenges of Distributing COVID-19 Antibody Drugs

by Samantha McGrail

Although prepublication news releases for COVID-19 antibody drugs are common, they often leave clinicians uncertain about how to best leverage the treatments, which are usually in short supply,...

FDA Publishes List of Essential Medicines to Address COVID-19

by Samantha McGrail

FDA recently published a list of 223 essential medicines, medical countermeasures, critical inputs to have available at all times and serve patient needs in the appropriate dosage forms. The product...

NIH Challenges Use of Convalescent Plasma to Treat COVID-19

by Samantha McGrail

After substantial review, NIH’s COVID-19 Treatment Guidelines Panel found that there were insufficient data to recommend either for or against the use of convalescent plasma for the treatment of...

FDA Expands Remdesivir Use to All Hospitalized COVID-19 Patients

by Samantha McGrail

FDA recently broadened an emergency use authorization for remdesivir to include all hospitalized adult and pediatric patients with COVID-19. For more coronavirus updates, visit our resource page,...

FDA Authorizes Use of Convalescent Plasma as COVID-19 Treatment

by Samantha McGrail

FDA announced yesterday that it issued an emergency use authorization (EUA) for investigational convalescent plasma as a COVID-19 treatment in hospitalized patients. For more coronavirus updates,...

Recent Articles